FindTrial
Sign In

The etiology and prognosis of rapidly progressing interstitial lung disease(RP-ILD): a prospective, single-center, cohort study

The etiology and prognosis of rapidly progressing interstitial lung disease(RP-ILD): a prospective, single-center, cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052178
Enrollment
Unknown
Registered
2021-10-20
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rapidly progressing interstitial lung disease(RP-ILD)

Interventions

Case series:No

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Interstitial changes such as ground-glass opacity on HRCT in the chest were significantly aggravated; 2. The total lung volume decreased by more than 10% or the PaO2 decreased by more than 1.33kPa; 3. Worsening of respiratory symptoms (dyspnea).

Exclusion criteria

Exclusion criteria: Lack of chest HRCT.

Design outcomes

Primary

MeasureTime frame
Establish a clinical diagnosis and treatment information database for rapidly progressing interstitial lung disease;—

Secondary

MeasureTime frame
mortality rate;progression-free survival rate;—

Countries

China

Contacts

Public ContactHan Qian

The First Affiliated Hospital of Guangzhou Medical University

453025247@qq.com+86 17324233395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026